While the U.S. and Iran are preoccupied with their ongoing war, China is moving full speed ahead with experiments involving - but not limited to - deadlier versions of COVIDVideo Summary:>A preprint study from China details a SARS-CoV-2-related pangolin coronavirus (named GX_P2V). The virus was tested on transgenic mice that were genetically modified to express human ACE2 receptors (the same receptors the COVID-19 virus uses to infect human cells).>GX_P2V is not a wild-type virus found in nature. It is a mutant virus that arose in a laboratory cell culture and was subsequently cloned by researchers to study its danger levels and pathogenicity. It is believed to have undergone a virulence-enhancing mutation. The virus caused a 100% mortality rate in the infected mice, with all subjects dying within 7 to 8 days of inoculation.>Infected mice displayed weight loss, piloerection (hair standing on end), a hunched posture, sluggish movements, and their eyes turned white. Unlike standard COVID-19, which often causes severe lung inflammation or a cytokine storm, this mutant virus killed the mice via late-stage brain infection (encephalitis). Viral loads initially appeared in the respiratory system but ultimately concentrated heavily in the brain and eyes.>Because the virus binds to human ACE2 receptors, and these receptors are prevalent in the human brain (e.g., in the brainstem, hypothalamus, and cerebral blood vessels), a spillover could theoretically cause a highly lethal brain infection in humans.>The authors of the study are linked to several Chinese institutions, including the Beijing Advanced Innovation Center and Nanjing University, and notably includes a doctor with ties to the Chinese military. This type of dangerous virological research is likely happening in military and civilian labs all over the world, not just in China, likening it to a biological "arms race." Research Link: >https://www.biorxiv.org/content/10.1101/2024.01.03.574008v1.full.pdf
>>529468171this boomer doomer STILL doing this?
>>529468244Vaxxed?
